ScinoPharm Taiwan, Ltd. financial statements
ScinoPharm Taiwan, Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | TWD 3.16B | EODHD |
| Net income | TWD 136.95M | EODHD |
| Cash and equivalents | TWD 3.11B | EODHD |
| Total debt | TWD 762.67M | EODHD |
ScinoPharm Taiwan, Ltd. financials on 6ix · ScinoPharm Taiwan, Ltd. on 6ix